Rodriguez-Torres Rafael, Kanner Cara H, Gay Emma L, Uher David, Corbeil Thomas, Coratti Giorgia, Dunaway Young Sally, Rohwer Annemarie, Muni Lofra Robert, McDermott Michael P, De Vivo Darryl C, Wall Melanie M, Glynn Nancy W, Montes Jacqueline
Departments of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Neurology, Columbia University Irving Medical Center, New York, NY, USA.
J Neuromuscul Dis. 2025 Jan-Feb;12(1):22143602241313326. doi: 10.1177/22143602241313326.
Fatigue and fatigability are commonly reported in spinal muscular atrophy (SMA). Physical fatigability, proposed to be the most relevant to SMA pathophysiology, encompasses performance-based and perceived physical fatigability (PPF) assessments. While performance-based measures have highlighted physical fatigability as an SMA hallmark, PPF is not well characterized due to the lack of disease- and construct-specific scales.
Our aim was to create a patient-reported outcome measure tailored for SMA, named the SMA EFFORT, to improve PPF assessment. Here, we describe the scale development process, assess scale properties, and discuss future research and application.
SMA and scale development experts organized a comprehensive physical activity item bank, relevant across the SMA phenotypic spectrum. Activities were systematically categorized by varying intensities and durations. The SMA EFFORT was completed by an international cohort of individuals with all types of SMA. To compare PPF across demographic and clinical variables, SMA EFFORT PPF percent (PPF%) composite scoring was established.
One hundred eighteen participants completed the SMA EFFORT. Total PPF% scores were broadly distributed within functional groups, with differences between non-sitters (35.1 ± 21.0) and sitters (24.9 ± 15.1) (= 0.006), and those with (34.4 ± 18.1) and without respiratory support (26.4 ± 17.8) (= 0.02). Participants treated with disease modifying therapy (DMT) showed similar scores to those without treatment (= 0.70). Further, no differences in scores were observed in participants with scoliosis surgery and those without (= 0.71). Subscale analyses revealed differences in mean PPF% subscale scores by functional group.
The novel SMA EFFORT standardizes PPF ratings by anchoring activity to intensity and duration. Item and scale data insights will inform the next iteration, which will undergo additional investigation. The SMA EFFORT aims to improve upon current measures to better assess treatment impact on physical well-being across the SMA spectrum.
疲劳和易疲劳性在脊髓性肌萎缩症(SMA)中普遍存在。身体易疲劳性被认为与SMA病理生理学最为相关,包括基于表现的身体易疲劳性和感知身体易疲劳性(PPF)评估。虽然基于表现的测量方法突出了身体易疲劳性是SMA的一个标志,但由于缺乏针对疾病和结构的特定量表,PPF尚未得到很好的描述。
我们的目标是创建一种专门为SMA量身定制的患者报告结局测量方法,称为SMA努力程度量表(SMA EFFORT),以改善PPF评估。在此,我们描述量表的开发过程,评估量表特性,并讨论未来的研究和应用。
SMA和量表开发专家组织了一个全面的身体活动项目库,涵盖SMA表型谱的各个方面。活动根据不同的强度和持续时间进行系统分类。SMA努力程度量表由来自世界各地的各类SMA患者完成。为了比较不同人口统计学和临床变量之间的PPF,建立了SMA努力程度量表PPF百分比(PPF%)综合评分。
118名参与者完成了SMA努力程度量表。总PPF%得分在功能组中分布广泛,非坐立者(35.1±21.0)和坐立者(24.9±15.1)之间存在差异(P = 0.006),以及有(34.4±18.1)和无呼吸支持(26.4±17.8)之间存在差异(P = 0.02)。接受疾病修饰治疗(DMT)的参与者得分与未接受治疗的参与者相似(P = 0.70)。此外,脊柱侧弯手术患者和未进行手术的患者得分没有差异(P = 0.71)。子量表分析显示不同功能组的平均PPF%子量表得分存在差异。
新型SMA努力程度量表通过将活动与强度和持续时间挂钩,使PPF评级标准化。项目和量表数据的见解将为下一次迭代提供参考,下一次迭代将进行更多研究。SMA努力程度量表旨在改进当前的测量方法,以更好地评估治疗对整个SMA谱系身体状况的影响。